sell

(redirected from L-selectin)
Also found in: Dictionary, Thesaurus, Medical, Financial, Wikipedia.
Related to L-selectin: E-selectin

sell

v. to transfer possession and ownership goods or other property for money or something of equivalent value. (See: sale)

sell

verb auction, barter, bring to market, deal in, dispose of for profit, divendere, drive a trade, effect a sale, exchange, furnish, give title to, handle, hawk, make a sale, market, merchandise, offer for sale, peddle, provide, put on sale, put up for sale, trade in, traffic in, transfer for a consideration, vend, vendere
See also: deal, handle, liquidate, persuade, trade, vend
References in periodicals archive ?
Parma first showed data from in vitro experiments demonstrating that the Company's L-selectin oligonucleotide antagonist binds to L-selectin on the surface of white blood cells such as neutrophils, lymphocytes and monocytes.
The NeXstar Pharmaceuticals' aptamers, however, binds to L-selectin at least hundreds of times more tightly than do any known small molecules under development, and thus are active at far lower doses.
1- To identify new proteins interacting with L-selectin tail and identify which one are important for L-selectin functions;
On the other hand, adhesion molecule L-selectin (CD62L) facilitates adherence of leukocytes to vascular endothelium and subsequent migration of leukocytes between endothelial cells into infected tissue (Perkins et al.
Jensen GS, Hart AN, Zaske LA, et al Mobilization of human CD34+ CD133+ and CD34+ CD133(-) sterm cells in vivo by consumption of an extract from Aphanizomenon flos-aquae-related to modulation of CXCR4 expression by an L-selectin ligand?
For instance, CEA, the glycoprotein commonly used as a marker for colorectal cancer (Clinical Tests Based on Cancer-Related Changes in Glycosylation above), and CD44, a highly glycosylated cell-surface adhesion protein, can serve as E- and L-selectin ligands (74).
Antibody to E- and l-selectin does not prevent lung injury or mortality in septic baboons.
The baby (at this stage referred to as an embryo by scientists) and the lining of the uterus both secrete a protein called L-selectin.
The team discovered that the placental cells make L-selectin, a protein usually seen on white blood cells, such as neutrophils.
University of California (Oakland, CA) has patented a composition to treat a variety of conditions including inflammation associated with trauma and with certain aspects of diseases such as rheumatoid arthritis, psoriasis, insulindependent diabetes, cutaneous lymphomas, duodenal ulcer, chronic proctitis, lymphocytic thyroidiris, hemorphagic shock, reperfusion injury during transplantation and multiple sclerosis, which include a chlorate or selenate which inhibits the natural biochemical sulfation process and/or a sulfatase enzyme which removes a sulfate from a specific position of a saccharide molecule which makes up a part of a natural ligand for L-selectin.
In well-conducted experiments, preparations of AFA containing a novel cyanobacterial ligand for human L-selectin were shown to have an important role in stem cell biology.
A hematopoietic cell L-selectin ligand that is distinct from PSGL-1 and displays N-glycan-dependent binding activity.